Finally, donor-type CD44+CD8+ effector T cells purified from the GC-treated BM cells expressed granzyme B and mediated equivalent killing on a per-cell basis to the vehicle-treated T cells in redirected cytolysis assays against leukemia cells (Figure 1I). This evidence concerns the gene CD44 and leukemia.